We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 2,985

Batting down generic plaintiffs’ Amarin Hail Mary pass
  • Reed Smith LLP
  • USA
  • August 27 2015

We received a couple of odd anonymous comments to our "breaking news" post about the Amarin First Amendment victory for truthful off-label promotion


Pharmaceutical Cos. Can make truthful, non-misleading claims about off-label uses, New York court rules
  • Manatt Phelps & Phillips LLP
  • USA
  • August 27 2015

Respecting the First Amendment rights of businesses to make truthful claims, a federal court judge in New York said the Food and Drug Administration


SDNY dismisses manufacturing and fraud claims in fertility drug case, but conflates and confuses the rest
  • Reed Smith LLP
  • USA
  • August 26 2015

By all rights, it should be Sullivan writing about the Sullivan case. But John is taking a well-deserved vacation. We do not know if Sullivan's


A case of the end of summer blahs
  • Dechert LLP
  • USA
  • August 25 2015

August 25th. How can that be? Some of us are still using the red, white and blue napkins we purchased for the Fourth of July. Jersey corn is sweet


WLF Working Paper assesses Ninth Circuit preemption decision
  • Kelley Drye & Warren LLP
  • USA
  • August 25 2015

In Reid v. Johnson & Johnson, the Ninth Circuit heard an appeal of one of the many state law-based consumer class actions over food labeling. A new


District court grants partial dismissal in Part DMedicaid case alleging false comparative marketing claims
  • Sidley Austin LLP
  • USA
  • August 25 2015

On August 20, 2015, the District of New Jersey granted in part and denied in part defendants' motion to dismiss allegations that by making


Preemption (and other things) defanging Depakote claims
  • Reed Smith LLP
  • USA
  • August 24 2015

It wasn't a complete win, but the summary judgment outcome in Rheinfrank v. Abbott Laboratories, Inc., ___ F. Supp.3d ___, 2015 WL 4743056 (S.D. Ohio


Central District of California discontinues much of Plaintiffs' experts' testimony in Cymbalta discontinuation symptoms case
  • Reed Smith LLP
  • USA
  • August 22 2015

"I'm not a doctor, but I play one on TV" - shorthand for "I am pretending to know what I'm talking about, but I really don't." We have blogged


PMA medical device preemption decision better late than never
  • Reed Smith LLP
  • USA
  • August 20 2015

We recently learned of Thomas v. Alcon Laboratories, ___ F. Supp.3d ___, 2013 WL 10888983 (N.D. Ga. Jan. 29, 2013), dismissing a contact lens product


Life sciences companies and free $& speech
  • Arnall Golden Gregory LLP
  • USA
  • August 19 2015

Irish and NI life sciences companies operating in the US likely are familiar with the concept of "off-label" promotion-providing information about